BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 29577418)

  • 1. Methadone-Not a magic bullet in melanoma therapy.
    Brüggen MC; Mangana J; Irmisch A; French LE; Levesque MP; Cheng PF; Dummer R
    Exp Dermatol; 2018 Jun; 27(6):694-696. PubMed ID: 29577418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dubious effects of methadone as an "anticancer" drug on ovarian cancer cell-lines and patient-derived tumor-spheroids.
    Fiegl H; Hagenbuchner J; Kyvelidou C; Seeber B; Sopper S; Tsibulak I; Wieser V; Reiser E; Roessler J; Huhtinen K; Carpén O; Parson W; Sprung S; Marth C; Ausserlechner MJ; Zeimet AG
    Gynecol Oncol; 2022 Apr; 165(1):129-136. PubMed ID: 35033381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DL-Methadone as an Enhancer of Chemotherapeutic Drugs in Head and Neck Cancer Cell Lines.
    Landgraf V; Griessmann M; Roller J; Polednik C; Schmidt M
    Anticancer Res; 2019 Jul; 39(7):3633-3639. PubMed ID: 31262889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumoral action of 2-deoxy-D-glucose tetraacetate in human melanoma cells.
    Reinhold U; Ugurel S; Tilgen W; Kadiata MM; Olivares E; Nadi AB; Malaisse WJ
    Oncol Rep; 2000; 7(5):1093-7. PubMed ID: 10948345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrochemotherapy with bleomycin and cisplatin enhances cytotoxicity in primary and metastatic uveal melanoma cell lines in vitro.
    Fiorentzis M; Kalirai H; Katopodis P; Seitz B; Viestenz A; Coupland SE
    Neoplasma; 2018; 65(2):210-215. PubMed ID: 29534581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of D,L-methadone in the treatment of glioblastoma in vitro.
    Brawanski K; Brockhoff G; Hau P; Vollmann-Zwerenz A; Freyschlag C; Lohmeier A; Riemenschneider MJ; Thomé C; Brawanski A; Proescholdt MA
    CNS Oncol; 2018 Jul; 7(3):CNS18. PubMed ID: 29916277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uveal melanoma expresses NK-1 receptors and cyclosporin A induces apoptosis in human melanoma cell lines overexpressing the NK-1 receptor.
    González-Ortega A; Sánchez-Vaderrábanos E; Ramiro-Fuentes S; Salinas-Martín MV; Carranza A; Coveñas R; Muñoz M
    Peptides; 2014 May; 55():1-12. PubMed ID: 24548567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
    Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
    Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of SB injection in canine osteosarcoma and melanoma cell lines.
    Kweon K; Ahn JO; Song WJ; Li Q; Lee BY; Chae HK; Youn HY
    In Vitro Cell Dev Biol Anim; 2019 Jan; 55(1):7-16. PubMed ID: 30382494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
    Oueslati B; Moula O; Ghachem R
    Pharmacogenomics; 2018 Jun; 19(8):741-747. PubMed ID: 29785888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression levels of OPRM1 and PDYN in human SH-SY5Y cells treated with morphine and methadone.
    Saify K; Saadat M
    Life Sci; 2016 Apr; 150():39-41. PubMed ID: 26921635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D,L-Methadone does not improve radio- and chemotherapy in glioblastoma in vitro.
    Oppermann H; Matusova M; Glasow A; Dietterle J; Baran-Schmidt R; Neumann K; Meixensberger J; Gaunitz F
    Cancer Chemother Pharmacol; 2019 Jun; 83(6):1017-1024. PubMed ID: 30888463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Methadone on Cisplatin Treatment of Bladder Cancer Cells.
    Michalska M; Schultze-Seemann S; Kuckuck I; Katzenwadel A; Wolf P
    Anticancer Res; 2018 Mar; 38(3):1369-1375. PubMed ID: 29491061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1.
    Niessner H; Kosnopfel C; Sinnberg T; Beck D; Krieg K; Wanke I; Lasithiotakis K; Bonin M; Garbe C; Meier F
    Exp Dermatol; 2017 Jul; 26(7):598-606. PubMed ID: 28423208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
    Dong YB; Yang HL; Elliott MJ; McMasters KM
    Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D,L-Methadone enhances the cytotoxic activity of standard chemotherapeutic agents on pediatric rhabdomyosarcoma.
    Urla C; Corteletti I; Raible AS; Handgretinger R; Fuchs J; Warmann SW; Schmid E
    J Cancer Res Clin Oncol; 2022 Jun; 148(6):1337-1350. PubMed ID: 35182225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients.
    Wang SC; Tsou HH; Chen CH; Chen YT; Ho IK; Hsiao CF; Chou SY; Lin YF; Fang KC; Huang CL; Su LW; Fang YC; Liu ML; Wu HY; Lin KM; Liu SC; Kuo HW; Chiang IC; Chen AC; Tian JN; Liu YL
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):695-703. PubMed ID: 22406240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting boosts sensitivity of human skin melanoma to cisplatin-induced cell death.
    Antunes F; Corazzari M; Pereira G; Fimia GM; Piacentini M; Smaili S
    Biochem Biophys Res Commun; 2017 Mar; 485(1):16-22. PubMed ID: 27693581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent USP10/13 antagonist spautin-1 suppresses melanoma growth via ROS-mediated DNA damage and exhibits synergy with cisplatin.
    Guo J; Zhang J; Liang L; Liu N; Qi M; Zhao S; Su J; Liu J; Peng C; Chen X; Liu H
    J Cell Mol Med; 2020 Apr; 24(7):4324-4340. PubMed ID: 32129945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed determination of the in vitro optimal chemocombinations of sphaeropsidin A with chemotherapeutic agents to combat melanomas.
    Ingels A; Dinhof C; Garg AD; Maddau L; Masi M; Evidente A; Berger W; Dejaegher B; Mathieu V
    Cancer Chemother Pharmacol; 2017 May; 79(5):971-983. PubMed ID: 28389780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.